
15,000 sq ft licensed processor has rec sales licence & multiple provincial sales agreements
Versatile, 15,000 sq. ft. standard processing facility suitable for a range of production, packaging, sales and distribution activities in Bowmanville, ON
Listing ID:
4235701888
Licence(s) Held:
Standard Cultivation, Standard Processing, Sales for Medical Purposes, Recreational Sales Amendment, CRA Cannabis Licence

Listing Details:
Purpose-designed, well-built, 15,000 ft.² processing building that offers a turnkey opportunity for cannabis cultivation, 2.0 processing/manufacturing and sales
13 Processing/production rooms, 2 secure storage areas, QC lab, Second floor office space, shipping and receiving area, and other ancillary spaces
Site is suitable for a wide range of processing related activities including pre-rolls, dried flower packaging, hash production, vape filling, co-packing, distribution, etc…
Leased facility with low operating costs
Additional leasable space immediately adjacent which would facilitate expansion or additional synergistic cannabis partners
As a licensed space, there is minimal delay for buyer to obtain its own license if that is the preferred transaction structure
Looking for divestiture
OUR NEWEST CANNABIS BUSINESS LISTINGS
Explore the newest cannabis business opportunities hitting the market. If you're looking to invest, acquire, or expand your enterprise, these listings are the ideal starting point to grow your footprint in the cannabis industry.
36324927098
Licensed Colombian medical cannabis platform targeting EU pharmaceutical market seeks $3M equity partner

Premium, fully licensed Colombian cannabis cultivation platform offering pharmaceutical-grade production at industry-leading costs, with secured European market access and scalable growth potential
29345918591
State-of-the-art, ~130,000 sq. ft. production facility with 20.5 tonnes annual capacity and & EU-GMP designed processing hub

Opportunity to acquire a custom-designed, ~130,000 sq. ft. turnkey production asset including 84,000 square feet of canopy designed for pharmaceutical-grade output. This unique opportunity allows for a clean-slate acquisition of world-class infrastructure providing an immediate entry point into the global medicinal and premium international markets.


